Nature Reviews Cancer

Top Research Topics at Nature Reviews Cancer?

Cancer research, Cancer, Cell biology, Internal medicine and Oncology are among the topics commonly tackled in Nature Reviews Cancer. The research on Cancer research tackled can also make contributions to studies in the areas of Carcinogenesis, Suppressor, Pathology, Metastasis and Stem cell. Cancer research presented in it encompasses a variety of subjects, including Disease, Immunology and Bioinformatics.

Nature Reviews Cancer concentrated on Immunology research, specifically Immune system and Immunotherapy. The work on Cell biology presented in the journal focuses on Signal transduction in particular. Internal medicine research presented is mostly focused on the subject of Breast cancer.

Gene is a major topic of Genetics research presented in it.

• Cancer research (30.61%)
• Cancer (24.35%)
• Cell biology (13.31%)

What are the most cited papers published in the journal?

• The blockade of immune checkpoints in cancer immunotherapy (7764 citations)
• MicroRNA signatures in human cancers (5704 citations)
• Epithelial–mesenchymal transitions in tumour progression (5387 citations)

Research areas of the most cited articles at Nature Reviews Cancer:

The journal articles primarily focus on research topics in Cancer, Cancer research, Immunology, Cell biology and Carcinogenesis. The published articles focus on Cancer but sometimes tackle the closely related topic of Pharmacology which is concerned with Drug resistance. The journal publications hold forums on Cancer research that merge themes from other disciplines such as Tyrosine kinase, Cancer therapy and Pathology.

What topics the last edition of the journal is best known for?

• Gene
• Cancer
• Internal medicine

The previous edition focused in particular on these issues:

Nature Reviews Cancer is organized to address concerns in the fields of Cancer research, Cancer, Immune system, Cancer cell and MEDLINE. The journal addresses concerns in Cancer research which are intertwined with other disciplines, such as Cell, Carcinogenesis, Suppressor, Metastasis and Immunotherapy. The majority of Cancer studies in it are focused on the subject of Tumor microenvironment.

While it focused on Cancer cell, it was also able to explore topics like Chromatin and Cell biology. The featured Cell biology studies mainly concentrate on Transcription (biology) but also cover areas of interest in Epigenetics. It holds forums on MEDLINE that merges themes from other disciplines such as Gerontology, Oncology, Family medicine, Journal club and Internal medicine.

The most cited articles from the last journal are:

• RNA in cancer. (104 citations)
• The rediscovery of platinum-based cancer therapy (55 citations)
• Mutations and mechanisms of WNT pathway tumour suppressors in cancer. (44 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Nature Reviews Cancer (based on the number of publications) are:

• Nicola McCarthy (361 papers) absent at the last edition,
• Sarah Seton-Rogers (315 papers) published 10 papers at the last edition, 2 less than at the previous edition,
• Gemma K. Alderton (215 papers) absent at the last edition,
• Kristine Novak (112 papers) absent at the last edition,
• Ezzie Hutchinson (97 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Nature Reviews Cancer (based on the number of publications) are:

• Harvard University (119 papers) published 7 papers at the last edition, 5 less than at the previous edition,
• Memorial Sloan Kettering Cancer Center (69 papers) published 2 papers at the last edition, 8 less than at the previous edition,
• National Institutes of Health (58 papers) published 1 paper at the last edition, 4 less than at the previous edition,
• University of California, San Francisco (48 papers) published 2 papers at the last edition, 5 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (44 papers) published 3 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 32.14% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.00% of all publications and 32.89% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Professional Development and Licensing Requirements for Cancer Researchers

For researchers looking to contribute to the wealth of knowledge within the sphere of cancer research, it’s important to understand that certain roles and titles may come with professional requirements. For instance, some positions may need relevant academic degrees, completed research projects, and even specific licenses or certifications. For nurses specifically who are interested in cancer research, obtaining a nursing license is a necessary step. The nursing license necessitates certain prerequisites according to the board of nursing in each respective state or region. For those aiming to practice in Texas, details about the various prerequisites, and process can be found on the texas Nursing license requirements board of nursing requirements page. This is beneficial for any nurse wanting to partake in cancer research as it provides them with a comprehensive guide about what is to be expected, and how to proceed. It's crucial for potential researchers to understand and complete these requirements so they can add their unique perspectives, findings, and insights in cancer research. Additionally, having a licensed healthcare professional like a nurse in the research team ensures clinical relevance and applicability. It also allows for direct patient interaction which may enrich the quality of the research. Emphasizing multidisciplinary teams in research allows us to tackle cancer from all angles, enhancing the potential for breakthroughs.